🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Eddie Hickman

Stock Analyst at Guggenheim

(4.25)
# 1,489
Out of 5,144 analysts
52
Total ratings
56.2%
Success rate
18.4%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Eddie Hickman

GH Research
Nov 18, 2026
Reiterated: Buy
Price Target: $40 → $46
Current: $19.93
Upside: +130.81%
ProMIS Neurosciences
Nov 16, 2026
Reiterated: Buy
Price Target: $100
Current: $3.52
Upside: +2,740.91%
Zevra Therapeutics
Nov 16, 2026
Maintained: Buy
Price Target: $23 → $18
Current: $11.17
Upside: +61.15%
Tarsus Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $89 → $97
Current: $69.07
Upside: +40.44%
Outlook Therapeutics
Aug 28, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.4621
Upside: n/a
Immunovant
Aug 11, 2025
Reiterated: Buy
Price Target: $44
Current: $29.90
Upside: n/a